Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

• Status: Terminated
• Trial end date: 2012-05-01

Summary

Time-to-Progression (TTP)

• Phase: Phase 2

Details

• Lead Sponsor: Stanford University
• Collaborator: Celgene Corporation
• Treatments: Lenalidomide; Thalidomide